Development of a high-throughput method to screen novel antiviral materials

Area of Science:

• Materials Science
• Virology
• Biotechnology

Background:

• Respiratory infectious diseases represent a significant global health challenge, necessitating the development of new antiviral materials.
• Photocatalytic nanoparticles are explored as surface coatings to mitigate pathogen transmission.
• Bacteriophages serve as safe and efficient model viruses for antiviral material development and screening.

Purpose of the Study:

• To construct and validate a novel platform for evaluating the antiviral activity of surface coating materials.
• To utilize the M13 bacteriophage and phagemid system for high-throughput screening of antiviral agents.
• To accelerate the discovery and development of effective antiviral materials.

Main Methods:

• Development of a screening platform based on the M13 bacteriophage and phage display technology.
• Evaluation of antiviral activity of surface coating materials using the constructed platform.
• Comparative analysis of results with traditional screening methods using Qβ bacteriophage and influenza virus.

Main Results:

• The novel platform successfully evaluated the antiviral activity of two tested materials.
• Results obtained from the new system were comparable to those from traditional screening methods.
• The M13 bacteriophage system demonstrated effectiveness in assessing antiviral surface coatings.

Conclusions:

• The developed experimental system offers a rapid and effective method for screening antiviral materials.
• This platform can be applied to accelerate the development of novel antiviral surface coatings.
• The M13 bacteriophage-based system provides a valuable tool for antiviral research and development.